Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
6.00
+0.09 (1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pulmatrix Employees
Pulmatrix had 22 employees as of December 31, 2023. The number of employees decreased by 7 or -24.14% compared to the previous year.
Employees
22
Change (1Y)
-7
Growth (1Y)
-24.14%
Revenue / Employee
$454,773
Profits / Employee
-$438,909
Market Cap
21.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
Athira Pharma | 67 |
Equillium | 44 |
NeurAxis | 19 |
GeoVax Labs | 17 |
iBio, Inc. | 16 |
Cocrystal Pharma | 12 |
NanoViricides | 7 |
PULM News
- 5 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - Accesswire
- 5 weeks ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 5 weeks ago - Pulmatrix and Cullgen Announce Proposed Merger - PRNewsWire
- 6 weeks ago - Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 7 months ago - Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation - PRNewsWire
- 7 months ago - Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - PRNewsWire
- 8 months ago - Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire